GENCURIX

Gencurix advances precision oncology with biomarker-based diagnostics for CLIA labs and hospital labs, enhancing patient selection and prognosis. Our digital PCR solutions focus on companion diagnostics. Key products include the Droplex Series (e.g., NSCLC EGFR, Breast Cancer PIK3CA/ESR1, Endometrial Cancer POLE) and the Droplex Cancer Panel for NSCLC. We also offer GenesWell BCT for predicting chemotherapy benefit in breast cancer.